Introduction
Cardiovascular atherosclerotic disease is the main cause of death in the Western world (1) . Clinical events such as myocardial infarction and ischemic cerebrovascular accident are directly related to the risk of atherosclerotic plaque rupture. Histological analysis of a vulnerable plaque suggests the importance of necrotic core size, extent of inflammation, and angiogenesis, lipid accumulation, and fibrous cap thickness (2) . Furthermore, in plaque vulnerability matrix metalloproteinase's (MMPs), reactive oxygen species, inflammatory cytokines and various growth factors released by activated macrophages play important roles (3) . Patients with symptoms and carotid artery stenosis >70% or those asymptomatic with carotid artery stenosis of 80-90%, are deemed suitable for endarterectomy thereby significantly reducing the risk of subsequent major cerebrovascular accident or death (4) . Imaging techniques currently used to visualize carotid artery stenosis include duplex ultrasound, computed tomography angiography (CTA) and angiography (5) . However, these techniques focus on anatomic features of the plaque and barely give any information on molecular and cellular processes. They therefore cannot distinguish between stable and unstable plaques. As plaque composition rather than stenosis is important in detecting an unstable plaque, new imaging modalities are needed (5) . content in a rabbit model, while in vivo quantification did not support this finding, possibly due to high accumulation in surrounding tissue (6) . Folate receptor β (FR-β) is present on activated macrophages, but not on resting macrophages or other immune cells. For that reason it might be a good indicator for inflammation in the human atherosclerotic carotid plaque, as previously shown by imaging carotid artery specimens with fluorescence labeled folate (7) . Furthermore, Ayala-López et al. localized activated macrophages in apolipoprotein E knockout mice fed a western diet using a 99m Tc-folate labeled compound (8) .
A heterogeneous population of macrophages exists including a classically activated macrophage type (M1) as well as an alternatively activated macrophage population (M2) (9) . The M1 macrophage is thought to have pro-inflammatory properties and polarization in vitro is driven by interferon gamma and low concentration lipopolysacharride.
Macrophages are driven towards the M2 type when the environment includes IL-4 and IL-10 (10). However, polarization of macrophages within a plaque is determined by the local micro-environment present in the atherosclerotic lesion and is thought to be rather more complex than the often used M1/M2 paradigm (11) . As MMPs trigger plaque rupture, a M2-like macrophage type might be important as a direct cause of plaque vulnerability by producing tissue degrading MMPs (12) . Therefore, the major goal of this pilot study was to explore the distribution of macrophage 104 CHAPTER 7 subtypes in atherosclerotic plaques and the FR-β expression on the respective macrophage subtypes. In addition, the potential of technetium labeled folate as marker for atherosclerotic carotid plaque vulnerability was explored. To achieve this goal, the 99m Tcfolate signal was compared with FR-β staining using specimens with a positive imaging ratio (accumulation slice/total plaque accumulation>1) to validate the folate technetium compound. Additionally, macrophages were differentiated and polarized in vitro into M1like and M2-like macrophages to investigate expression of FR-β and known M1 and M2 markers.
Materials and Methods

Study Design
Between August 2011 and May 2012, a total of 20 carotid specimens were obtained by means of carotid endarterectomy (CEA) of the carotid bifurcation using standard techniques (13) . Patients underwent open carotid surgery at the University Medical Center Groningen (UMCG) and were symptomatic (i.e. with a history of recent cerebrovascular accident (CVA)), transient ischaemic attack (TIA) or amaurosis fugax). They presented with a stenosis of the common carotid artery of 70-99% as detected by duplex ultrasound.
Additionally, asymptomatic patients with a stenosis of 80-99%, found by routine control were eligible for surgical treatment. Risk factors such as hyperlipidemia, hypertension, smoking status, obesity (body mass index, BMI) and diabetes mellitus were recorded.
Hyperlipidemia and hypertension was defined as described before by our group (7) . For validation of macrophage markers six healthy volunteers where included without known cardiovascular disease or risk factors. The study was approved by the Institutional Review Board (IRB) of the UMCG and informed consent was obtained from all patients and healthy volunteers.
Carotid Endarterectomy Sample Collection and Timepath of Study
The carotid samples collected during CEA, were immediately transported in a phosphate buffer on ice to the U-SPECT-II system (MILabs, Utrecht, The Netherlands), with a mean transport time of 18±6 minutes. The optimal incubation time and concentration of 99m Tcfolate was determined. To validate the 99m Tc-folate signal, immunohistochemistry was used for determining M1-like and M2-like macrophage levels in regions with high and low 99m Tcfolate accumulation. 
Tc-folate Labeling and Imaging of the Plaque using μSPECT
To determine the exact location where the 99m Tc-folate accumulation had taken place within the plaque, ex vivo imaging was performed. A 99m Tc-labeled imaging agent consisting of the vitamin folic acid was conjugated to a chelating agent with specificity for 99m Tc was used as follows; 1mL of Sodium Pertechnetate 99m Tc injection (100 MBq) was injected into a 105 99M Tc-FOLATE IMAGING; ANALYZING MACROPHAGE SUBTYPES IN PLAQUES shielded vial. The vial was gently swirled for 30 seconds to dissolve the lyophilized powder and placed into a lead shield and incubated at 100 °C for 18 minutes. Subsequently, the 99m Tc-folate vial was cooled for 15 minutes protected from light, and the radiochemical purity of 99m Tc-folate was determined by ITLC using saline as the eluent. The radiochemical purity must be >90% to pass acceptance criteria. The carotid specimens were weighed and incubated for one hour in 5mL of a 99m Tc-folate containing solution at room temperature.
After washing 99m Tc-folate accumulation was measured using the dose calibrator. The specimens were put into a micro single-photon emission computed tomography (μSPECT) scanner, near the center of field of view (FOV) and scanned for one hour (as determined by serial dilution). μSPECT images were corrected for scatter and reconstructed applying an interactive reconstruction algorithm (OSEM 2D). After incubation and scanning, all specimens were divided in equal slices of 3mm. For every slice the mean accumulation was calculated as counts/voxel of Region of Interest (ROI) versus total dose calibrator activity per gram (total plaque weight), expressed as MBq/g. Images acquired were processed using Amide software (14) .
Immunohistochemistry and Validation of 99m Tc-folate Signal
After determining 99m Tc-folate accumulation of every slice, slices of plaques of 10 patients 
In Vitro Differentiation and Polarization of M1-like and M2-like Macrophages
Peripheral blood mononuclear cells (PBMCs) were isolated from 6 healthy donors by density gradient centrifugation using Lymphoprep (Axis Shield PoC As, Oslo, Norway).
Subsequently, monocytes were allowed to adhere to culture plates. The adherent cells were maintained for 5 days in RPMI 1640 medium (Lonza, Walkersville, MD, USA) supplemented with 10% filtered fetal calf serum (FCS). 20 ng/ml macrophage colony stimulating factor (M-CSF, R&D systems) was added to the cell culture for differentiation into macrophages. Macrophages were directed towards M1-like and M2-like phenotypes by use of 48 hours stimulation with 100 U/ml interferon gamma (PeproTech, USA) and 1 ng/ ml lipopolysacharride (Sigma, Germany) or 20 ng/ml IL-4 and 10ng/ml IL-10 (PeproTech), respectively.
Flow Cytometry of M1-like and M2-like Macrophages
In vitro differentiated M1-like and M2-like macrophages were stained with biotinylated antihuman FR-β antibody (R&D systems) to explore protein expression. Streptavidineallophycocyanine (APC, Biolegend, San Diego, CA, USA) was used as secondary antibody.
Anti-CD86-FITC (BD Bioscience, San Jose, CA, USA) and anti-CD163-PE (Biolegend) were used to distinguish expression of these markers on macrophage subtypes. These were measured using flow cytometry.
RNA Isolation, cDNA Synthesis and qRT-PCR
RNA was extracted from M1-like and M2-like macrophages as described before (7) . 
Results
Patient Characteristics
A total of 12 men and eight women with a mean age of 68.0 ± 8.4 years were included.
Patient characteristics are shown in Table 1 .
Imaging of the Plaque using μSPECT
Imaging of 20 atherosclerotic plaques using µSPECT showed 99m Tc-folate accumulation occurred in specific areas of the plaques, with a median total activity of 2.45 (0.77-6.40) MBq/g measured in a dose calibrator (figure 1). After scanning all specimens were divided in equal slices and ratio per slice was calculated (accumulation slice/total plaque accumulation). There were 5 ± 1 slices per atherosclerotic carotid plaque. 99m Tc-folate accumulation was heterogeneously distributed throughout plaques (slices with highest 99m Tc-folate ratio: 1.28 (1.03-2.24) and slices with the lowest 99m Tc-folate ratio: 0.8 (0.18-0.99)). 
Immunohistochemistry and Validation of 99m Tc-folate Signal
Plaque slices of 10 patients were stained using FR-β to validate the 99m Tc-folate signal, as well as for CD68 (pan macrophages), CD86 and iNOS (M1 macrophage markers) and CD163 (M2 macrophage marker). In figure 2A representative staining is shown. All stainings were quantified with Imagescope software and expressed as percentage of positive cells per total cells. Slices with a positive 99m Tc-folate imaging ratio (accumulation slice/total plaque accumulation >1) where positively correlated to FR-β staining (P =0.006, figure 2B ). 
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Expression of Macrophage Markers by Flow Cytometry
To validate FR-β, CD86 and CD163 as macrophage subtype markers, their expression Isotypes in black in all graphs. 112 CHAPTER 7 In Vitro mRNA Expression of M1-like and M2-like Markers mRNA levels of GAPDH, IL-6, TNF, TLR-2 and -4, FR-β, MR, IL-10 and MMP-9 were determined in M1-like and M2-like differentiated macrophages in duplicate from 6 healthy volunteers.
mRNA expression of FR-β, MR, IL-10 and MMP-9 was increased in M2-like macrophages compared to M1-like macrophages (P=0.09, P=0.04, P=0.06 and P=0.004, respectively, figure 5 ). On the contrary, TNF and TLR-2 mRNA levels were significantly higher in M1-like macrophages compared to those in M2-like macrophages (see figure 6 , P=0.002 for both).
No significant difference could be found in mRNA levels of IL-6 and TLR-4 between M1-like and M2-like macrophages. 
Discussion
This is the first study to show feasibility using 99m Tc-folate to image human atherosclerotic carotid plaques ex vivo. Slices with the highest 99m Tc-folate accumulation showed significantly more FR-β and CD163 expression compared to slices with lowest 99m Tcfolate accumulation, and significantly less expression of iNOS. Therefore, FR-β positive macrophages were found to be primarily M2-like polarized macrophages, which might be pro-atherogenic, due to production of matrix degrading enzymes.
A number of research groups succeeded in specifying macrophage subsets expressing the folate receptor on tumor-associated M2 macrophages (16) , and on M2 macrophages expressed in experimental allergic asthma in mice (17) . Furthermore, FR-β targeted immunotoxin treatment resulted in reduction of macrophages and plaque progression (18) . However, by our knowledge this is the first study to show an overexpression of FR-β on M2-like macrophages in atherosclerosis. Nevertheless, identification of macrophage subtypes and determination of their role in the atherosclerotic process is still a major challenge.
The M1 and M2 macrophage subtypes are observed in atherosclerotic lesions previously (19, 20) . Shaikh et al. found a higher proportion of M1 pro-inflammatory macrophages and a reduced proportion of M2-cells in symptomatic carotid lesions (21) . The discrepancy 114 CHAPTER 7 to our study could be due to the fact that the former study compared the ratio of macrophage subtypes in the carotid artery to those in vascular femoral plaques. (23) . Furthermore, patients with a 2.4 fold increased cardiovascular risk compared to patients with a low ratio, were found to have a high MMP-12/CD68 ratio (24) .
MMP-12 was found to be correlated with MMP-9 positive macrophage subpopulations in a mouse model for obesity (25) . Stöger et al found a correlation between areas of intraplaque hemorrhage and CD163 staining in human atherosclerosis. During development of plaques both M1 and M2 cells accumulated, and the fibrous caps of lesions showed no significant differences between subsets. In contrast, vascular adventitial tissue displayed a pronounced M2 activation profile (26) . These different studies support our hypothesis that accumulation of M2-like macrophages might be indicative of plaque vulnerability, which can be imaged by 99m Tc-folate imaging.
Visualizing folate receptors has been performed before using optical fluorescent contrast agent (FITC) labeled to folate by our group (7) . Other groups also used optical imaging for the identification of tumor processes, as several solid tumors express folate receptor α, demonstrated in ovarian cancer (27) and in head-and neck carcinoma expressing folate receptor-β (28) . However, applications for non-invasive optical imaging of fluorescent signals by the use of fluorophores such as FITC could be of less clinical value because of the limited penetration depth of only a few millimeters. This could be extended to a few centimeters using near infrared (NIR) probes, but not ideal for the use in coronary arteries for instance. 99m Tc-folate has a good tissue penetration and a relatively short half life. Furthermore its radiolabeling procedure is simple and it has not shown toxicity or immunogenicity (8) . (33) has been shown to selectively target FR-β positive macrophages in atherosclerotic plaques (34) . No determination of differential folate accumulation in the respective M1-like and M2-like subpopulation was performed in this study. [ 18 F]fluoro-PEG-folate has been used in a rat model of arthritis to image (sub)clinical arthritis (35) . For imaging of plaque inflammation 2-deoxy-2-[ 18 F]fluoro-D-mannose ([ 18 F] FDM), has been developed recently, supporting a higher accumulation in macrophages compared to [ 18 F]FDG (23) .
A limitation of our study is that division of macrophages solely as M1 or M2 subtypes may be too simple. As Wolfs et al. suggests the role of the local micro-environment makes macrophage polarization in the atherosclerotic tissue more complex than the typically described M1 and M2 macrophages distribution (11) . So, not only cytokine environment, but also foam cell formation and CXCL4 (chemokine ligand 4, forming M4 macrophages), among other factors, play major roles. This could be an explanation for the fact that in 
